
    
      Selection of CD34+THY-1 Positive Cells From Peripheral Blood Cells Procured for Autologous
      Hematopoietic Support Following High Dose Treatment with BCNU, Cyclophosphamide & Cisplatin
      for Stage IV Breast Cancer & Limited Prior Treatment
    
  